Form D · Other Health Care
Dermal Photonics Corp
Danvers, MA · CIK 0001797421
Offering snapshot reported Oct 13, 2021 · SEC filing
- Reported sold
- $580K Offering amount: $1.5M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $250 Reported outside-investor minimum
- First sale
- Aug 31, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2021 | Initial | $580,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-416666
Source: Form D, filed Oct 13, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Bean | Director |
| Curtis Ersing | Director |
| Petter Etholm | Director |
| Daniel Pulver | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
153 Andover St Suite 111
Danvers, MA, 01923
Danvers, MA, 01923